Yu Xia - 17 Jan 2023 Form 3 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Ankur Dhingra, as Attorney-in-Fact for Yu Xia
Issuer symbol
SMMT
Transactions as of
17 Jan 2023
Transactions value $
$0
Form type
3
Filing time
26 Jan 2023, 13:48:49 UTC
Next filing
14 Feb 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney